Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol products. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
Nectar Lifesciences Dividend Announcement
• Nectar Lifesciences announced a semi annually dividend of ₹0.05 per ordinary share which will be made payable on . Ex dividend date: 2020-09-18
• Nectar Lifesciences's trailing twelve-month (TTM) dividend yield is -%
Nectar Lifesciences Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2020-09-18 | ₹0.05 | semi annually | |
2020-09-11 | ₹0.05 | semi annually | 2020-10-21 |
2019-09-19 | ₹0.05 | semi annually | 2019-10-27 |
2018-09-19 | ₹0.05 | semi annually | 2018-10-27 |
2017-09-20 | ₹0.05 | semi annually | 2017-10-28 |
2016-09-22 | ₹0.10 | semi annually | 2016-10-30 |
2015-09-22 | ₹0.10 | semi annually | 2015-10-28 |
2014-08-21 | ₹0.10 | semi annually | 2014-10-30 |
2013-09-19 | ₹0.10 | semi annually | 2013-10-29 |
2012-09-20 | ₹0.10 | semi annually | 2012-10-28 |
2011-09-21 | ₹0.10 | semi annually | 2011-10-29 |
2010-01-21 | ₹0.25 | semi annually | 2010-03-13 |
2009-09-03 | ₹0.10 | semi annually | 2009-10-21 |
Nectar Lifesciences Dividend per year
Nectar Lifesciences Dividend growth
Nectar Lifesciences Dividend Yield
Nectar Lifesciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Nectar Lifesciences stock? Use our calculator to estimate your expected dividend yield:
Nectar Lifesciences Financial Ratios
Nectar Lifesciences Dividend FAQ
Other factors to consider when evaluating Nectar Lifesciences as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Nectar Lifesciences stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Nectar Lifesciences's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Nectar Lifesciences publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Nectar Lifesciences distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Nectar Lifesciences are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Nectar Lifesciences sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Nectar Lifesciences distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Nectar Lifesciences declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Nectar Lifesciences's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Nectar Lifesciences's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.